Literature DB >> 3443166

Procoagulant activities in human alveolar macrophages.

B Nakstad1, N P Boye, T Lyberg.   

Abstract

The coexistence of fibrin and tissue macrophages is a common finding in the histopathology of chronic lung inflammatory diseases. Human lung alveolar macrophages (LAM) obtained by lavage of healthy donors can initiate the coagulation sequence by expressing procoagulant factors. The procoagulants of LAM were in this study identified to be either thromboplastin (tissue factor) or a direct factor X activator, probably a thromboplastin/factor VII complex. LAM did not show inducible thromboplastin synthesis as did monocytes when stimulated in vitro. LAM were separated into four subpopulations by density gradient centrifugation. The specific thromboplastin activity of subpopulation cells varied inversely with their density. Low-density subpopulations of LAM released microvesicles from their surface which could be recovered in the culture medium, and which expressed procoagulant activities with the same characteristics as the LAM procoagulants. These findings suggest that alveolar macrophages and the membrane vesicles shed from their surface contribute to local fibrin deposition in the lungs by expressing procoagulant factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443166

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  3 in total

1.  Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns.

Authors:  S Peyrol; J F Cordier; J A Grimaud
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

2.  Heterogeneity of procoagulant activity and cytokine release in subpopulations of alveolar macrophages and monocytes.

Authors:  T S Haugen; B Nakstad; T Lyberg
Journal:  Inflammation       Date:  1999-02       Impact factor: 4.092

Review 3.  Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.

Authors:  W Seeger; A Günther; H D Walmrath; F Grimminger; H G Lasch
Journal:  Clin Investig       Date:  1993-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.